NEW YORK, Aug. 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in PepGen Inc. ("PepGen Inc." or the "Company") (NASDAQ: PEPG) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of PepGen Inc. investors who were adversely affected by alleged securities fraud between March 7, 2024 and March 3, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/pepgen-inc-lawsuit-submission-form? ...

NEW YORK, July 31, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of PepGen Inc. (NASDAQ: PEPG).Shareholders who purchased shares of PEPG during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/pepgen-inc-loss-submission-form/?id=158785&from=4 CLASS PERIOD: March 7, 2024 to March 3, 202 ...

NEW YORK, July 30, 2025 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PepGen Inc. (NASDAQ: PEPG) between March 7, 2024 and March 3, 2025, both dates inclusive (the "Class Period"), of the important August 8, 2025 lead plaintiff deadline.So What: If you purchased PepGen securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.What to do next: To j ...

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in PepGen Inc. ("PepGen Inc." or the "Company") (NASDAQ: PEPG) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of PepGen Inc. investors who were adversely affected by alleged securities fraud between March 7, 2024 and March 3, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/pepgen-inc-lawsuit-submissio ...

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PepGen Inc. (NASDAQ: PEPG) between March 7, 2024 and March 3, 2025, both dates inclusive (the “Class Period”), of the important August 8, 2025 lead plaintiff deadline. SO WHAT: If you purchased PepGen securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NE ...

ATLANTA, July 28, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against PepGen Inc. (“PepGen” or the “Company”) (NASDAQ: PEPG). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information about PepGen’s business, operations, and prospects, including allegations that: (i) PGN-EDO51 was less effective and safe than Defendants had led investors to believe; (ii) the CONNECT2 study was deficient for pur ...

NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in PepGen Inc. ("PepGen Inc." or the "Company") (NASDAQ: PEPG) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of PepGen Inc. investors who were adversely affected by alleged securities fraud between March 7, 2024 and March 3, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/pepgen-inc-lawsuit-submissio ...

NEW YORK, July 25, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in PepGen Inc. ("PepGen Inc." or the "Company") (NASDAQ: PEPG) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of PepGen Inc. investors who were adversely affected by alleged securities fraud between March 7, 2024 and March 3, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/pepgen-inc-lawsuit-submission-form ...

案件概述 - 罗森律师事务所提醒在2024年3月7日至2025年3月3日期间购买PepGen Inc (NASDAQ: PEPG)证券的投资者注意2025年8月8日的首席原告截止日期 [1] - 投资者可能有权通过风险代理协议获得赔偿而无需支付自付费用 [1] 诉讼细节 - 指控被告在集体诉讼期间作出虚假或误导性陈述包括PGN-EDO51的疗效和安全性低于公司宣称水平 [4] - CONNECT2研究存在缺陷可能影响FDA批准且公司可能因此暂停该研究 [4] - 上述因素导致PGN-ED051的临床、监管和商业前景被夸大 [4] - 真相披露后投资者遭受损失 [4] 律所背景 - 罗森律师事务所在证券集体诉讼领域具有领先地位曾创下针对中国公司的最大和解金额纪录 [3] - 2017年被ISS证券集体诉讼服务评为和解数量第一律所2013年起每年排名前四 [3] - 2019年为投资者追回4.38亿美元2020年创始合伙人Laurence Rosen被Law360评为原告律师界泰斗 [3] 参与方式 - 投资者可通过指定链接或联系方式加入集体诉讼首席原告需在2025年8月8日前向法院提出申请 [2][5] - 在集体认证前投资者需自行选择律师或保持缺席成员身份 [6]

诉讼案件概述 - 律师事务所Bragar Eagel & Squire代表投资者对PepGen公司提起集体诉讼，指控其在2024年3月7日至2025年3月3日期间发布虚假或误导性声明 [1] - 诉讼涉及PepGen公司证券的购买者或持有者，投资者需在2025年8月8日前申请成为首席原告 [1] 指控内容 - 公司被指控在业务、运营和前景方面发布虚假或误导性声明，包括夸大PGN-EDO51药物的有效性和安全性 [3] - 指控称CONNECT2研究存在安全隐患或缺陷，可能无法获得FDA批准，导致研究可能被叫停 [3] - 公司被指控隐瞒PGN-EDO51的临床、监管和商业前景的真实情况，导致投资者受损 [3] 投资者参与方式 - 投资者可通过电话、电子邮件或填写联系表格与律师事务所沟通，了解法律权利和索赔选项 [4] - 律师事务所提供免费咨询，投资者无需承担费用或义务 [4] 律师事务所背景 - Bragar Eagel & Squire是一家全国知名的律师事务所，专注于证券和商业诉讼，代表个人和机构投资者 [5] - 事务所在纽约、加利福尼亚和南卡罗来纳设有办公室，提供复杂诉讼服务 [5]